Thread Embedding Acupuncture for Rhinitis Allergy

Launched by UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY · Feb 27, 2025

Keywords

ClinConnect Summary

This clinical trial is looking into a treatment for allergic rhinitis, which is a common condition that causes symptoms like a runny nose, sneezing, and nasal congestion. The study will explore whether combining a type of acupuncture called thread embedding acupuncture (TEA) with a medication called inhaled corticosteroids (INCS) is more effective than using the medication alone. TEA is a method that has been used for various chronic conditions and has shown promise in helping patients feel better.

To participate in the trial, individuals aged 18 to 75 who experience typical symptoms of allergic rhinitis for at least one hour each day over the past two weeks may be eligible. It’s important that participants are not involved in any other clinical trials and do not have certain medical conditions, such as pregnancy or other serious health issues. Those who join the study can expect to receive either the combination treatment or the medication alone and will be monitored for both effectiveness and safety. This trial aims to provide valuable information about new treatment options for people suffering from allergic rhinitis.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Those not participating in any other clinical trial
• • Those who provide written informed consent
• • Those with typical symptoms of AR, rhinorrhea, sneezing, nasal obstruction, and pruritus. These symptoms should last at least one hour most day since last two week.
• Exclusion Criteria:
• • Pregnancy, lactation, or recent childbirth within the past 6 months.
• • Those were receiving immune therapy
• • Those with other allergic diseases such as bronchial asthma or allergic purpura
• • Those with nasal polyposis
• • Those with heterologous protein allergy
• • Those with other disorders such as AIDS, vascular malformation, hypertension, hematologic, diseases, diabetes mellitus, malignant tumor, or mental disorders.